UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Proposal for individualized dosing of eculizumab in atypical haemolytic uraemic syndrome: patient friendly and cost-effective

Nephrology, dialysis, transplantation, 2023-02, Vol.38 (2), p.362-371

2023

Volltextzugriff (PDF)

Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab

Nephrology, dialysis, transplantation, 2014-09, Vol.29 Suppl 4 (suppl 4), p.iv131-iv141

2014

Volltextzugriff (PDF)

A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome

Netherlands journal of medicine, 2012-04, Vol.70 (3), p.121-129

2012

Volltextzugriff (PDF)

Eculizumab Rescue Therapy in Patients With Recurrent Atypical Hemolytic Uremic Syndrome After Kidney Transplantation

Kidney international reports, 2023-04, Vol.8 (4), p.715-726

2023

Volltextzugriff (PDF)

Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis : report of four cases and review of the literature

Netherlands journal of medicine, 2008-11, Vol.66 (10), p.408-415

2008

Volltextzugriff (PDF)

Metastatic rhabdomyosarcoma cured after chemotherapy and allogeneic SCT

Bone marrow transplantation (Basingstoke), 2009-01, Vol.43 (2), p.179-180

2009

Volltextzugriff (PDF)

Living kidney transplantation in adult patients with atypical haemolytic uraemic syndrome

Netherlands journal of medicine, 2013-09, Vol.71 (7), p.342-347

2013

Volltextzugriff (PDF)

Characterization of verocytotoxin-producing Escherichia coli O157 isolates from patients with haemolytic uraemic syndrome in Western Europe

Epidemiology and infection, 1995-08, Vol.115 (1), p.1-3

1995

Volltextzugriff (PDF)

Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum

Kidney international, 2024-10

2024

Volltextzugriff (PDF)

Outcomes from the International Society of Nephrology Haemolytic Uraemic Syndromes International Forum

Kidney international, 2024-10

2024

Volltextzugriff (PDF)

Effects of TNFα on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells

Kidney international, 1997-04, Vol.51 (4), p.1245-1256

1997

Volltextzugriff (PDF)

Tumor Necrosis Factor and Interleukin-1 Induce Expression of the Verocytotoxin Receptor Globotriaosylceramide on Human Endothelial Cells: Implications for the Pathogenesis of the Hemolytic Uremic Syndrome

Blood, 1992-12, Vol.80 (11), p.2755-2764

1992

Volltextzugriff (PDF)

Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability : Evidence for two distinct mechanisms

Journal of the American Society of Nephrology, 1997-12, Vol.8 (12), p.1877-1888

1997

Volltextzugriff (PDF)

Tumor necrosis facto α induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C

Blood, 1995, Vol.85 (3), p.734-743

1995

Volltextzugriff (PDF)

Metastatic rhabdomyosarcoma cured after chemotherapy and allogeneic SCT

Bone marrow transplantation, 2009, Vol.43 (2), p.179-180

2009

Volltextzugriff (PDF)

Tumor necrosis factor and interleukin 1 induce expression of the glycolipid verotoxin receptor in human endothelial cells. Implications for the pathogenesis of the haemolytic uraemic syndrome

Behring Institute Mitteilungen, 1993-08 (92), p.202

1993

Volltextzugriff (PDF)

Mutations in Genes Encoding Subunits of the RNA Exosome as a Potential Novel Cause of Thrombotic Microangiopathy

International journal of molecular sciences, 2024-07, Vol.25 (14), p.7604

2024

Volltextzugriff (PDF)

Modeling complement activation on human glomerular microvascular endothelial cells

Frontiers in immunology, 2023-10, Vol.14, p.1206409-1206409

2023

Volltextzugriff (PDF)

COVID-19 vaccination and Atypical hemolytic uremic syndrome

Frontiers in immunology, 2022-12, Vol.13, p.1056153

2022

Volltextzugriff (PDF)

Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer: Results From an International Collaboration

Annals of surgery, 2019-02, Vol.269 (2), p.315-321

2019

Volltextzugriff (PDF)

Proteinuria and Exposure to Eculizumab in Atypical Hemolytic Uremic Syndrome

Clinical journal of the American Society of Nephrology, 2023-06, Vol.18 (6), p.759-766

2023

Volltextzugriff (PDF)

Case Report: Variable Pharmacokinetic Profile of Eculizumab in an aHUS Patient

Frontiers in immunology, 2021-01, Vol.11, p.612706

2021

Volltextzugriff (PDF)

Enough is enough: targeted eculizumab withdrawal in atypical hemolytic uremic syndrome

Kidney international, 2021-08, Vol.100 (2), p.265-268

2021

Volltextzugriff (PDF)

Trans-intestinal cholesterol efflux is not mediated through high density lipoprotein

Journal of lipid research, 2012-10, Vol.53 (10), p.2017-2023

2012

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Aktive Filter

ThemaInfant

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(55)
Bücher
(1)
Berichte
(1)

Sprache

Englisch
(54)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(39)
Humans
(26)
Biological And Medical Sciences
(14)
Urology & Nephrology
(14)
Atypical Hemolytic Uremic Syndrome
(12)
Medical Sciences
(11)
Eculizumab
(9)
Male
(9)
Female
(8)
Adult
(7)
Child
(7)
Complement
(6)
Immunology
(6)
Nephrology. Urinary Tract Diseases
(6)
Nephropathies. Renovascular Diseases. Renal Failure
(6)
Ahus
(5)
Animals
(5)
Fundamental And Applied Biological Sciences. Psychology
(5)
General & Internal Medicine
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Proposal for individualized dosing of eculizumab in atypical haemolytic uraemic syndrome: patient friendly and cost-effective

Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab

A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome

Eculizumab Rescue Therapy in Patients With Recurrent Atypical Hemolytic Uremic Syndrome After Kidney Transplantation

Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis : report of four cases and review of the literature

Metastatic rhabdomyosarcoma cured after chemotherapy and allogeneic SCT

Living kidney transplantation in adult patients with atypical haemolytic uraemic syndrome

Characterization of verocytotoxin-producing Escherichia coli O157 isolates from patients with haemolytic uraemic syndrome in Western Europe

Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum

Outcomes from the International Society of Nephrology Haemolytic Uraemic Syndromes International Forum

Effects of TNFα on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells

Tumor Necrosis Factor and Interleukin-1 Induce Expression of the Verocytotoxin Receptor Globotriaosylceramide on Human Endothelial Cells: Implications for the Pathogenesis of the Hemolytic Uremic Syndrome

Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability : Evidence for two distinct mechanisms

Tumor necrosis facto α induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C

Metastatic rhabdomyosarcoma cured after chemotherapy and allogeneic SCT

Tumor necrosis factor and interleukin 1 induce expression of the glycolipid verotoxin receptor in human endothelial cells. Implications for the pathogenesis of the haemolytic uraemic syndrome

Mutations in Genes Encoding Subunits of the RNA Exosome as a Potential Novel Cause of Thrombotic Microangiopathy

Modeling complement activation on human glomerular microvascular endothelial cells

COVID-19 vaccination and Atypical hemolytic uremic syndrome

Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer: Results From an International Collaboration

Proteinuria and Exposure to Eculizumab in Atypical Hemolytic Uremic Syndrome

Case Report: Variable Pharmacokinetic Profile of Eculizumab in an aHUS Patient

Enough is enough: targeted eculizumab withdrawal in atypical hemolytic uremic syndrome

Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study

Trans-intestinal cholesterol efflux is not mediated through high density lipoprotein

Aktive Filter

Suchergebnisse filtern